Athenahealth, Inc.
ATHN
ATHN was delisted on the 11th of February, 2019.
235 hedge funds and large institutions have $6.19B invested in Athenahealth, Inc. in 2017 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 75 increasing their positions, 80 reducing their positions, and 36 closing their positions.
426% more call options, than puts
Call options by funds: $352M | Put options by funds: $66.9M
28% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 36
7% more capital invested
Capital invested by funds: $5.77B → $6.19B (+$420M)
4% more funds holding
Funds holding: 227 → 235 (+8)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
6% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 80
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NAMA
Nikko Asset Management Americas
New York
|
+$69.7M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$58.6M |
| 3 |
Janus Henderson Group
London,
|
+$53.3M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$49.6M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$34.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$114M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
-$97.8M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$28M |
| 4 |
RCG
Ruane, Cunniff & Goldfarb
New York
|
-$24.9M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$23.8M |
ATHN Hedge Fund Activity: Q4 2017 in Review
235 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Athenahealth, Inc. (ATHN) for Q4 2017, worth a combined $6.19B — up 7.3% from $5.77B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new ATHN positions and 36 closed out — a net gain of 10 holders — while 75 added to existing stakes and 80 trimmed.
The largest buyer was Nikko Asset Management Americas, adding an estimated $69.7M. The largest seller was Fidelity Investments, cutting an estimated $114M.
- 235 institutional investors held Athenahealth, Inc. (ATHN) as of Q4 2017, up from 227 in Q3 2017.
- Funds reported $6.19B of Athenahealth, Inc. stock for Q4 2017, up 7.3% quarter-over-quarter.
- 46 funds opened new Athenahealth, Inc. positions in Q4 2017 and 36 closed out, a net change of +10 holders.
- The largest Athenahealth, Inc. buyer in Q4 2017 was Nikko Asset Management Americas, an estimated $69.7M added.
- The largest Athenahealth, Inc. seller in Q4 2017 was Fidelity Investments, an estimated $114M sold.
Based on aggregated 13F filings for Q4 2017.